ACTSI Investigator Dr. Walter Curran in the News

Walter Curran Jr., MD, ACTSI investigator, Lawrence W. Davis Professor and Chair of radiation oncology, and chief medical officer and executive director of Winship Cancer Institute, Emory University

Atlanta Business Chronicle | Curran runs Winship Cancer Institute
April 8, 2016

Winship News | Winship Executive Director Authors NEJM Study
April 6, 2016

Winship News | "Fashion a Cure" raises $170,000 for cancer research
March 2, 2016

Hem/Onc Today | Winship Cancer Institute appoints new deputy director
February 14, 2016

CNN | Is the cure for cancer real or rhetoric?
January 14, 2016

Emory Medicine | Caring for President Carter
Winter 2016

Gold Medalists to be Honored at ACR2016-The Crossroads of Radiology
October 28, 2015 | Carter's cancer fight reflects change in treatment of elderly
August 26, 2015

Associated Press | Cancer forces Jimmy Carter to slow down but not stop work
August 24, 2015

Atlanta Journal-Constitution | Treating Jimmy Carter's cancer
August 24, 2015

Curran was appointed to serve on a new, seven-person advisory panel to NASA. The NASA Research and

Clinical Advisory Panel (RCAP) will advise NASA on research opportunities and priorities and finding decisions related to the national space and aeronautic programs.

New York Times | ABC News, Bloomberg, NBC News, CNN,NPR , Reuters, Wall Street Journal, Washington Post | Ailing Jimmy Carter 'at ease with whatever comes'
August 20, 2015

Video: Curran discusses proton therapy at ASCO 2015

Video: Curran previews Winship discoveries at ASCO 2015

MedPage Today | Oncologists weigh in on Ken Burns' cancer documentary
April 14, 2015

Winship Research Featured in New ASCO Annual Progress Report
Research studies from two Winship Cancer Institute experts are highlighted in the newly released Annual Report on Progress Against Cancer from the American Society of Clinical Oncology (ASCO). Curran is senior author of a paper featured in the report that shows survival is extended for certain patients with low grade brain tumors who are treated with a combination of chemotherapy and radiotherapy. The study, sponsored by the Radiation Therapy Oncology Group (RTOG, now under NRG

Oncology’s auspices), was presented at the 2014 ASCO Annual Meeting and published in abstract form in the Journal of Clinical Oncology (JCO). ASCO notes that combination therapy has proven “enormously effective against many types of cancer.”

MedPage Today | ASCO Oncologists: Why I tweet
June 5, 2014

Georgia Trend | Help and Hope: When it comes to finding a cure for childhood cancer, Georgia is leading the charge
April 2014

Health Imaging Hub | Adding bevacizumab to initial glibolastoma treatment does not improve overall survival
February 24, 2014

Medical News Today | Overall survival not improved by adding bevacizumab to initial glioblastoma treatment
February 21, 2014

Curran was elected in 2014 to a radiation oncologist seat on the American Society of Clinical Oncology board of directors.

CNN | WHO: Imminent global cancer 'disaster' reflects aging, lifestyle factors
February 4, 2014

Curran is listed as 19th  among more than 35,000 researchers nationwide in a ranking of principal investigator recipients of NIH research dollars in 2013, according to the Blue Ridge Institute for Medical Research. Read more.

The Oncology Report | Sequester continuing to hit cancer research hard
December 4, 2013

WABE | Head of Emory's Winship Cancer Institute: Sequestration taking toll
December 4, 2013

Atlanta Business Chronicle | Winship's Curran named GRA Eminent Scholar
September 11, 2013

Emory News Center | Georgia Research Alliance names Winship Cancer Institute director a GRA Eminent Scholar
September 11, 2013

Atlanta Business Chronicle | Health-Care Quarterly Who's Who in Health Care: Celebrating Atlanta's top minds in health care
January 25, 2013

Curran received a special award from the American College of Radiology “in recognition of 17 years of service and leadership as Chair of the Radiation Therapy Oncology Group.”